HARVARD BIOSCIENCE INC's ticker is HBIO and the CUSIP is 416906105. A total of 101 filers reported holding HARVARD BIOSCIENCE INC in Q2 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $97,020 | +51.6% | 23,100 | 0.0% | 0.00% | – |
| Q4 2022 | $63,987 | – | 23,100 | +109900.0% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 21 | -99.8% | 0.00% | – |
| Q4 2020 | $47,000 | -72.8% | 10,914 | -82.0% | 0.00% | – |
| Q2 2016 | $173,000 | +367.6% | 60,635 | +479.3% | 0.00% | – |
| Q4 2015 | $37,000 | -5.1% | 10,467 | +0.8% | 0.00% | – |
| Q3 2015 | $39,000 | -36.1% | 10,380 | -2.8% | 0.00% | – |
| Q2 2015 | $61,000 | -80.4% | 10,679 | -80.1% | 0.00% | – |
| Q1 2015 | $312,000 | +96.2% | 53,630 | +91.8% | 0.00% | – |
| Q4 2014 | $159,000 | -38.8% | 27,966 | -51.0% | 0.00% | – |
| Q2 2014 | $260,000 | +28.1% | 57,117 | +33.6% | 0.00% | – |
| Q1 2014 | $203,000 | +28.5% | 42,759 | +27.2% | 0.00% | – |
| Q4 2013 | $158,000 | +24.4% | 33,625 | +38.3% | 0.00% | – |
| Q3 2013 | $127,000 | +47.7% | 24,310 | +33.5% | 0.00% | – |
| Q2 2013 | $86,000 | -25.2% | 18,203 | -10.6% | 0.00% | – |
| Q1 2013 | $115,000 | – | 20,360 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| First Light Asset Management, LLC | 2,744,128 | $8,370,000 | 3.68% |
| Glacier Peak Capital LLC | 1,156,332 | $3,527,000 | 2.03% |
| ICM ASSET MANAGEMENT INC/WA | 148,663 | $453,000 | 0.64% |
| BARD ASSOCIATES INC | 359,525 | $1,097,000 | 0.51% |
| Fondren Management LP | 230,000 | $702,000 | 0.50% |
| 22NW, LP | 190,333 | $581,000 | 0.35% |
| HEARTLAND ADVISORS INC | 2,000,000 | $6,100,000 | 0.34% |
| WOODMONT INVESTMENT COUNSEL LLC | 324,177 | $989,000 | 0.28% |
| Granahan Investment Management | 1,537,815 | $4,690,000 | 0.16% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 238,530 | $728,000 | 0.12% |